A Longitudinal Study of the Effects of a Gluten-Free Diet on Glycemic Control and Weight Gain in Subjects With Type 1 Diabetes and Celiac Disease
- Rakesh Amin, MRCP (UK)1,
- Nuala Murphy, MRCP (UK)2,
- Julie Edge, MD, FRCPCH2,
- Marion L. Ahmed, MPHIL2,
- Carlo L. Acerini, MRCP (UK)1 and
- David B. Dunger, MD, FRCP1
- 1University Department of Paediatrics, Addenbrooke’s Hospital, Cambridge, U.K.
- 2Department of Paediatrics, John Radcliffe Hospital, Oxford, U.K.
Abstract
OBJECTIVE—To describe the longitudinal growth characteristics and glycemic control in type 1 diabetic children diagnosed with celiac disease and started on a gluten-free diet (GFD).
RESEARCH DESIGN AND METHODS—Data on growth and glycemic control for 11 case subjects diagnosed with celiac disease (cd+ group) and started on a GFD were collected prospectively, and two control subjects without celiac disease matched for age, sex, and duration of diabetes (cd− group) were selected for comparison.
RESULTS—In the period between diagnosis of type 1 diabetes and start of a GFD in the cd+ compared with the cd− group, BMI standard deviation score (SDS) was lower (–0.2 vs. 0.7, P = 0.015), as was HbA1c (8.9 vs. 9.8%, P = 0.002). In a regression model the cd+ group had lower BMI SDS (P < 0.001) and lower HbA1c (P = 0.04), independent of other variables. On a GFD, BMI SDS increased by 12 months in the cd+ group and then was no different than the cd− group (1.1 vs. 1.0, P = 0.11), whereas HbA1c improved further within case subjects compared with pre-GFD (8.9 vs. 8.3%, P = 0.002). On a GFD, case subjects in contrast to control subjects showed no deterioration in HbA1c during the years of puberty (8.3 vs. 10.0%, P = 0.022)
CONCLUSIONS—In children with type 1 diabetes, untreated celiac disease resulted in lower BMI SDS and lower HbA1c. Recovery of BMI SDS with a GFD was associated with further improvement in HbA1c as compared with pre-GFD, with no expected deterioration in glycemic control during puberty. These apparent clinical benefits need confirming by larger studies.
- AGA, anti-gliadin antibodies
- CV, coefficient of variation
- EMA, anti-endomysial antibodies
- GFD, gluten-free diet
- SDS, standard deviation score
Footnotes
-
Address correspondence and reprint requests to Professor David B. Dunger, University Department of Paediatrics, Box 116, Level 8, Addenbrooke’s Hospital, Hill’s Road, Cambridge, U.K. CB2 2QQ. E-mail: dbd25{at}cam.ac.uk.
Received for publication 11 October 2001 and accepted in revised form 26 March 2002.
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
- DIABETES CARE














